The Global Fund's Malaria Medicine Subsidy : A Nice Idea with Nasty Implications

Phase 1 of the Affordable Medicines Facility for malaria (AMFm) is a $225 million initiative that was launched in 2010 in an effort to increase access to safe and effective artemisinin-based combination therapies (ACTs) by dramatically lowering their price with a global subsidy. The AMFm also seeks to drive out oral artemisinin monotherapies as their continued use threatens the entire class of drugs due to drug resistance

MoreLess

Year of publication:	2013
Authors:	Tren, Richard
Other Persons:	Bate, Roger (contributor) ; Hess, Kimberly (contributor) ; Ayodele, Thompson (contributor) ; Cudjoe, Franklin (contributor)
Publisher:	[2013]: [S.l.] : SSRN
Subject:	Tropenkrankheit \| Tropical disease \| Welt \| World \| Subvention \| Subsidy \| Gesundheitsvorsorge \| Preventive care \| Forschungsfinanzierung \| Research funding \| Arzneimittel \| Pharmaceuticals

freely available

Full text |

More access options

doi.org

Check Google Scholar

In German libraries (KVK)

I need help

Extent:	1 Online-Ressource (22 p)
Series:	Africa Fighting Malaria Policy Paper
Type of publication:	Book / Working Paper
Language:	English
Notes:	Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments September 8, 2011 erstellt
Other identifiers:	10.2139/ssrn.2342790 [DOI]
Source:	ECONIS - Online Catalogue of the ZBW

Persistent link: https://www.econbiz.de/10013074073